Oral anticoagulation with or without antiplatelet therapy for secondary stroke prevention in patients with atrial fibrillation and atherosclerosis: a systematic review and meta-analysis.
Patients with ischemic stroke (IS), atrial fibrillation (AF), and atherosclerosis have an increased risk of recurrent ischemic events. Addition of antiplatelet therapy (APT) to oral anticoagulant therapy (OAC) may offer additional protection against these events, at the cost of an increased risk of bleeding. This syste...